Global Ankle Fusion Nail Market is Segmented By Product Type (Uniplanar Nails, Multiplanar Nails, and Others), By Material (Stainless Steel, Titanium, and Others), By End User (Hospital, Ambulatory Surgery Centers, Orthopedic Clinics, and Others), By Indication (Osteoarthritis, Rheumatoid Arthritis, Post-traumatic Arthritis, and Others), By Fixation Type (Tibiotalocalcaneal Fusion, Pantalar Fusion, Tibiotalar Fusion, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The report offers the value (in USD million) for the above-mentioned segments.

Global Ankle Fusion Nail Market Size

Market Size in USD


Study Period2023 - 2030
Base Year of Estimation2022
Fastest Growing MarketAsia Pacific
Largest MarketNorth America
Market ConcentrationHigh
Major PlayersAcumed LLC, Arthrex Inc., Stryker Corporation, Smith & Nephew plc, Wright Medical Group N.V.
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !

Global Ankle Fusion Nail Market Analysis

The ankle fusion nail market size is expected to reach US$ 1,145.2 million by 2030, from US$ 630.5 million in 2023, at a CAGR of 8.9% during the forecast period. Ankle fusion nails are specialized implants used to fuse bones in the ankle joint to relieve chronic pain and improve stability. The surgery helps patients with severe ankle arthritis by eliminating motion and fusing the joint. Ankle fusion nails offer advantages like minimal soft tissue dissection, shorter operating time, and lower rates of nonunion. The rising cases of ankle arthritis and increasing road accidents are the key drivers for the market growth.

The ankle fusion nail market is segmented by product type, material, end-user, indication, fixation type, and region. By product type, the uniplanar nails segment accounts for the largest share of the market. Uniplanar nails provide compression across the tibiotalar joint and are commonly used for ankle arthrodesis procedures. Their simple design and ease of use are driving their adoption.

Ankle Fusion Nail Market Drivers

  • Rising Incidence of Ankle Arthritis: Ankle arthritis is one of the leading causes of ankle fusion procedures. The growing incidence of ankle osteoarthritis and rheumatoid arthritis due to obesity, genetics, injuries, and other factors is expected to increase the demand for ankle fusion nails. According to the Arthritis Foundation, in 2021, around 1.3 million Americans suffered from ankle arthritis. The American Orthopedic Foot and Ankle Society estimates around 6,000 and 7,000 ankle fusion procedures were performed in the U.S in 2021, every year due to arthritis. As the burden of ankle arthritis rises globally, the number of ankle fusion surgeries will increase, in turn fueling the growth of the ankle fusion nail market.
  • Technological Advancements in Implant Designs: Continuous advancements in implant designs and materials are driving the ankle fusion nail market growth. Companies are developing implants with anatomical shapes, improved locking mechanism, and coatings to enhance bone ingrowth. For instance, Acumed LLC, an orthopaedic medical device original equipment manufacturer; offers Ankle Fusion System featuring Agilon coated intramedullary nails for antibacterial protection. In 2021, Orthofix Medical Inc., a leading medical device company; launched VOS Ankle Fusion Nail with a fluted, tapered design, and four distal locking options. These product developments are improving fusion rates and surgical outcomes, thereby propelling market growth.
  • Increasing Road Accidents and Sports Injuries: The rising number of road traffic accidents and sports injuries leading to post-traumatic arthritis is boosting the demand for ankle arthrodesis. According to the World Health Organization (WHO), around 1.3 million people die annually due to road traffic crashes. Sport injuries like fractures, dislocations, and sprains causing ankle instability also require fusion procedures. Growing cases of trauma requiring ankle fusion are expected to support the adoption of specialized fusion nails and screws.
  • Rising Geriatric Population: The geriatric population is at a higher risk of degenerative bone disorders like osteoarthritis requiring ankle fusion surgery. According to the United Nation (UN), the global population aged 65 years and above is projected to reach 1.5 billion by 2050. The elderly are more prone to falls and injuries. With improving life expectancy, the growing aging population worldwide presents significant opportunities for market growth during the forecast period.

Ankle Fusion Nail Market Opportunities

  • Emerging Markets in Developing Countries: Emerging economies like China, India, Brazil and South Korea present lucrative opportunities owing to improving healthcare infrastructure and rising disposable incomes. The expanding target patient population, rise in medical tourism and growing awareness regarding advanced treatments create prospects for ankle fusion devices in these markets. Local player like Double Medical and global companies are increasing focus on emerging markets to capitalize on the untapped potential and gain share.

Ankle Fusion Nail Market Restraint

  • High Cost of Ankle Fusion Surgery: The high cost of ankle fusion surgery ranging between US$ 9,000 to US$ 28,000 in the U.S. depending on implants used and hospital charges is a major restraint limiting the adoption. Additionally, the cost of revision surgeries and expenses related to post-operative complications also add to the economic burden. Lack of favorable reimbursement and low awareness regarding treatable conditions in developing countries hamper uptake. Affordability concerns restrict access to a large patient pool, thereby hindering the market growth to some extent.
  • Risk of Nonunion and Other Post-operative Complications: The risks of nonunion, delayed union, and malunion after ankle arthrodesis reduce its clinical desirability and adoption. Post-operative complications like infections, wound issues, nerve injuries, thrombosis, and implant failures may require additional surgeries and hospital stays. These concerns and the extensive 8-12 months recovery period hampers patient preference for the surgery, thereby challenging the market expansion.
  • Limited Clinical Evidence Regarding Long-term Outcomes: There is limited high-quality clinical data comparing the long-term outcomes of ankle fusion using nails versus other surgical techniques. The lack of conclusive randomized controlled trials demonstrating clear benefits and disadvantages confuses surgeons regarding optimal implants and approaches. More research is warranted to establish strong clinical evidence and definitive best practice guidelines for ankle arthrodesis. The lack of robust clinical data can make surgeons apprehensive about adopting this technique, hindering the market growth.